Typical Chronic Myelogenous Leukemia With e19a2 Junction BCR/ABL Transcript-Reference-Cited by-同舟云学术

Typical Chronic Myelogenous Leukemia With e19a2 Junction BCR/ABL Transcript

Published:1997-12-15 Issue:12 Volume:90 Page:5024-5024
ISSN:1528-0020
Container-title:Blood
language:en
Short-container-title:

Author:

Briz Montserrat¹,Vilches Carlos¹,Cabrera Rafael¹,Forés Rafael¹,Fernández Manuel Nicolás¹

Affiliation:

1. Departments of Hematology and Immunology Hospital Puerta de Hierro Madrid, Spain

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/90/12/5024/1414049/5024.pdf

Reference7 articles.

1. New type of Bcr/Abl junction in Philadelphia chromosome-positive chronic myelogenous leukemia.;Saglio;Blood,1990

2. Establishment and molecular characterization of a novel leukemic cell line with Philadelphia chromosome expressing p230 BCR/ABL fusion protein.;Wada;Cancer Res,1995

3. Neutrophilic-chronic myeloid leukemia: A distinct disease with a specific molecular marker (BCR/ABL with C3/A2 junction).;Pane;Blood,1996

4. Elevated platelet count features the variant type of BCR/ABL junction in chronic myelogenous leukaemia.;Yamagata;Br J Haematol,1996

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Concurrence of e1a2 and e19a2 BCR-ABL1 Fusion Transcripts in a Typical Case of Chronic Myeloid Leukemia;Annals of Laboratory Medicine;2017-01-01

2. Chronic neutrophilic leukaemia;Journal of Clinical Pathology;2015-06-16

3. Molecular Response to Nilotinib in a Patient with Imatinib-intolerant e19a2-positive Chronic Myeloid Leukemia;Internal Medicine;2014

4. Targeted therapy of chronic myeloid leukemia;Biochemical Pharmacology;2010-09

5. Chronic neutrophilic leukemia and chronic myelomonocytic leukemia: WHO defined;Best Practice & Research Clinical Haematology;2006-09